The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Burd S.G.

Pirogov Russian National Research Medical University;
Federal center of brain research and neurotechnologies

Lebedeva A.V.

Moscow Research and Clinical Center for Neuropsychiatry of the Healthcare Department;
Pirogov Russian National Research Medical University;
Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare system of the Healthcare Department

Avakyan G.G.

Federal Center of Brain Research and Neurotechnologies;
Pirogov Russian National Research Medical University

Rubleva Yu.V.

Federal center of brain research and neurotechnologies

Pantina N.V.

Federal Center of Brain Research and Neurotechnologies

Yurchenko A.V.

Federal Center of Brain Research and Neurotechnologies

Kovaleva I.I.

Federal Center of Brain Research and Neurotechnologies

COVID-19-associated damage of the peripheral nervous system

Authors:

Burd S.G., Lebedeva A.V., Avakyan G.G., Rubleva Yu.V., Pantina N.V., Yurchenko A.V., Kovaleva I.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9): 15‑21

DOI: 10.17116/jnevro202212209115

Read: 7824 times

Contact the author
Table of contents

COVID-19-ASSOCIATED DAMAGE OF THE PERIPHERAL NERVOUS SYSTEM
COVID-19-ASSOCIATED DAMAGE OF THE PERIPHERAL NERVOUS SYSTEM

To cite this article:

Burd SG, Lebedeva AV, Avakyan GG, Rubleva YuV, Pantina NV, Yurchenko AV, Kovaleva II. COVID-19-associated damage of the peripheral nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9):15‑21. (In Russ.)
https://doi.org/10.17116/jnevro202212209115

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sleep diso­rders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132
Effe­ctiveness and tole­rability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):90-98
Markers of inflammation and angiogenesis in patients with ischemic stroke after the new coro­navirus infe­ction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):100-103
Atte­ndance of oral surgeons per one inha­bitant per year in the subjects of the Russian Fede­ration in 2017—2023. Stomatology. 2025;(3):53-56
Atte­ndance of dental surgeons for diseases in the Russian Fede­ration in 2017—2023. Stomatology. 2025;(4):62-65
Sarcoid reaction with focal inte­rstitial fibrosis in a COVID-19 patient with persistence of Sars-Cov-2 virus nucleocapsid and adhe­sion proteins in sarcoid granulomas and lung tissue. Russian Journal of Archive of Pathology. 2025;(4):54-57
Features of lung cancer carcinogenesis invo­lving cancer stem cells in COVID-19. Effe­cts of photodynamic therapy in the treatment of cancer and COVID-19. Russian Journal of Archive of Pathology. 2025;(5):65-73
Multimorbidity, risk factors and causes of death in patients with cardiovascular diseases during long-term posthospital moni­toring. Russian Journal of Preventive Medi­cine. 2025;(11):36-44
Coro­naviruses in human pathophysiology: a brief history of the COVID-19 pandemic. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):55-63
Poly­morphic variants of IL23R, IL6, IL28B, IL17F genes in patients who have survived after coro­navirus SARS-CoV-2 infe­ction. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):129-134
Abstract:

Based on the available literature data, the article discusses the prevalence of various forms of damage of the peripheral nervous system in COVID-19 and in the post-COVID period. Information about the clinical features and the course of individual cranial neuropathies, chronic dysimmune neuropathies, Guillain—Barré syndrome, drug-induced neuropathies, fine fiber neuropathy, myasthenia gravis and polyneuropathy of critical conditions was systemized in the context of coronavirus infection. SARS-CoV-2 can trigger various stages of pathogenesis, including neuroimmune ones, which cause long-term consequences of COVID-19, including those associated with the damage of the peripheral nervous system. Awareness of COVID-19-associated pathological conditions will allow assessment of the possible risks of damage of the peripheral nervous system, recognize them at early stages and develop more effective approaches for treatment.

Keywords:

coronavirus infection
COVID-19
SARS-CoV-2
post-COVID syndrome
peripheral nervous system

Authors:

Burd S.G.

Pirogov Russian National Research Medical University;
Federal center of brain research and neurotechnologies

Lebedeva A.V.

Moscow Research and Clinical Center for Neuropsychiatry of the Healthcare Department;
Pirogov Russian National Research Medical University;
Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare system of the Healthcare Department

Avakyan G.G.

Federal Center of Brain Research and Neurotechnologies;
Pirogov Russian National Research Medical University

Rubleva Yu.V.

Federal center of brain research and neurotechnologies

Pantina N.V.

Federal Center of Brain Research and Neurotechnologies

Yurchenko A.V.

Federal Center of Brain Research and Neurotechnologies

Kovaleva I.I.

Federal Center of Brain Research and Neurotechnologies

Received:

27.04.2022

Accepted:

18.05.2022

Close metadata

References:

  1. Paterson RW, Brown RL, Benjamin L, et al.The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104-3120. https://doi.org/10.1093/brain/awaa240
  2. Andalib S, Biller J, Di Napoli M, et al. Peripheral Nervous System ManifestationsAssociated with COVID-19. Curr Neurol Neurosci Rep. 2021;21(3):9.  https://doi.org/10.1007/s11910-021-01102-5
  3. Rifino N, Censori B, Agazzi E, et al. Neurologic manifestations in 1760COVID‐19 patients admitted to Papa Giovanni XXIII Hospital, Ber-gamo, Italy. J Neurol. 2021;268(7):2331‐2338. https://doi.org/10.1007/s00415‐020‐10251‐5
  4. Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsy-chiatric complications of COVID‐19 in 153 patients: a UK‐wide sur-veillance study. Lancet Psychiatry. 2020;7:875‐882.  https://doi.org/10.1016/S2215‐0366(20)30287‐X
  5. Dolgopolov IS, Mentkevich GL, Rykov MY, Chichanovskaya LV. Neurological disorders in patients with long COVID syndrome and cell therapy methods for their correction: a literature review. Sechenov Medical Journal. 2021;(12):3. (In Russ.). https://doi.org/10.47093/2218-7332.2021.12.3.56-67
  6. Belopasov VV, Zhuravleva EN, Nugmanova NP, Abdrashitova AT. Post-covid-19 neurological syndromes. Journal of Clinical Practice. 2021;12(2):69-82. (In Russ.) https://doi.org/10.17816/clinpract71137
  7. Belopasov VV, Yachou Y, Samoilova EM, Baklaushev VP. The nervous system damage in COVID-19. Journal of Clinical Practice. 2020;11(2):60-80. (In Russ.). https://doi.org/10.17816/clinpract34851
  8. Khrulev AE, Shiyanova NA, Sorokoumova SN, et al. Acute and chronic dysimmune polyneuropathies in the context of the COVID 19 pandemic: pathogenesis, features of the clinical picture, diagnosis and therapy (litera ture review). Nervno Myshechnye Bolezni = Neuromuscular Diseases. 2021;11(2):17-27. (In Russ). https://doi.org/10.17650/2222 8721 2021 11 2 17 27
  9. Stefanou M-I, Palaiodimou L, Bakolaet E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Therapeutic Advances in Chronic Disease. February 2022. https://doi.org/10.1177/20406223221076890
  10. Maksimova MYu, Grusha YaO, Fettser EI. COVID-19 associated multiple cranial neuropathies. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(1):99-103. (In Russ.). https://doi.org/10.14412/2074-2711-2022-1-99-103
  11. Finsterer J, Scorza FA, Scorza C, Fiorini A. COVID-19 associated cranial nerve neuropathy: A systematic review. Bosn J Basic Med Sci. 2021 Aug 11.  https://doi.org/10.17305/bjbms.2021.6341
  12. Arens T, Giuseppe L. COVID-19 and the Peripheral Nervous System. A 2-year review from the pandemic to the vaccine era. J Peripher Nerv Syst. 2022;27(1):4-30.  https://doi.org/10.1111/jns.12482
  13. Sharifian-Dorche M, Huot P, Osherov M, et al. Neurological complications of coronavirusinfection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020;417:117085. https://doi.org/10.1016/j.jns.2020.117085
  14. Rodrigo‐Armenteros P, Uterga‐Valiente JM, Zabala‐del‐Arco J, et al. Optic neuropathy in a patient with COVID‐19 infection. Acta Neurol Belg. 2021;21(6):1-3.  https://doi.org/10.1007/s13760‐021‐01600‐w
  15. François J, Collery AS, Hayek G, et al. Coronavirus disease2019‐associ-ated ocular neuropathy with panuveitis: a case report. JAMA Ophthalmol. 2021;139:247‐249.  https://doi.org/10.1001/jamaophthalmol.2020.5695
  16. Lima MA, Silva MTT, Soares CN, et al. Peripheral facialnerve palsy associated with COVID-19. J Neurovirol. 2020;26(6):941-944. Epub 2020 Oct 2.  https://doi.org/10.1007/s13365-020-00912-6
  17. Codeluppi L, Venturelli F, Rossi J, et al. Facial palsy during theCOVID‐19 pandemic. Brain Behav. 2021;11:e01939. https://doi.org/10.1002/brb3.1939
  18. Islamoglu Y, Celik B, Kiris M. Facial paralysis as the only symptom of COVID‐19: A prospective study. Am J Otolaryngol. 2021;42:102956. https://doi.org/10.1016/j.amjoto.2021.102956
  19. Kilic O, Kalcioglu MT, Cag Y, et al. Could sudden sensorineural hear-ing loss be the sole manifestation of COVID‐19? An investigation into SARS‐COV‐2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208‐211.  https://doi.org/10.1016/j.ijid.2020.06.023
  20. Degen C, Lenarz T, Willenborg K. Acute profound sensorineuralhearing loss after COVID‐19 pneumonia. Mayo Clin Proc. 2020;95:1801‐1803. https://doi.org/10.1016/j.mayocp.2020.05.034
  21. Abdel Rhman S, Abdel Wahid A. COVID‐19 and sudden sensorineural hearing loss, a case report. Otolaryngology Case Reports. 2020;16:100198. https://doi.org/10.1016/j.xocr.2020.100198
  22. Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self‐reported changes in hearing and tinnitus in post‐hospitalisationCOVID‐19 cases. Int J Audiol. 2020;59:889‐890.  https://doi.org/10.1080/14992027.2020.1798519
  23. Yachou Y, El Idrissi A, Belapasov V, AitBenali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657-2669. https://doi.org/10.1007/s10072-020-04575-3
  24. Deca vel P, Petit C, Tatu L. Tapia syndrome at the time of the COVID-19 pandemic: Lower cranial neuropathy following prolonged intubation. Neurology. 2020;95(7):312-313.  https://doi.org/10.1212/WNL.0000000000010011
  25. Khacha A, Bouchal S, Ettabyaoui A, et al. Cavernous sinus thrombosis in a COVID-19 patient: A case report. Radiol Case Rep. 2021;16(3):480-482.  https://doi.org/10.1016/j.radcr.2020.12.013
  26. Katyal N, Narula N, Acharya S, Govindarajan R. Neuromuscular complications with SARS-Cov-2 infection: a review. Front Neurol. 2020;11:1052. https://doi.org/10.3389/fneur.2020.01052
  27. Dos Santos Martins TG. Isolated post SARS-CoV-2 diplopia. J Neurol. 2021;268(2):391.  https://doi.org/10.1007/s00415-020-10072-6
  28. Trentinaglia M, Lippi G, Salvagno GL. Peripheral neuropathies during the COVID-19 pandemic: is there a relation? Immunol Res. 2022;23(7):1-6.  https://doi.org/10.1007/s12026-022-09272-1
  29. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):601-605.  https://doi.org/10.1212/WNL.0000000000009619
  30. Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020;95(5):221-223.  https://doi.org/10.1212/WNL.0000000000009700
  31. Lantos JE, Strauss SB, Lin E. COVID-19-associated Miller Fisher syndrome: MRI findings. Am J Neuroradiol. 2020;41(7):1184-1186. https://doi.org/10.3174/ajnr.A6609
  32. Fernández-Domínguez J, AmeijideSanluis E, García-Cabo C, et al. Miller Fisher-like syndrome related to SARSCoV-2 infection (COVID-19). J Neurol. 2020;267(9):2495-2496. PMID: 32458195. https://doi.org/10.1007/s00415-020-09912-2
  33. Kamchatnov PR, Evzelman MA, Chugunov AV. Peripheral nervous system disorders in COVID-19. RMJ. 2021;5:30-34. (In Russ.).
  34. Oaklander AL, Mills AJ, Kelley M, et al. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID. Neurology. Neuroimmunology & Neuroinflammation. March 1, 2022. https://doi.org/10.1212/NXI.0000000000001146
  35. Stein M, Bell MJ, Ang LC. Hydroxychloroquine neuromyotoxicity. J Rheumatol. 2000;27(12):2927-2931. PMID: 11128688.
  36. Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020;173(12):1027-1028. https://doi.org/10.7326/L20-0845
  37. Sriwastava S, Tandon M, Kataria S, et al. New onsetof ocular myasthenia gravis in a patient with COVID‐19: a novelcase report and literature review. J Neurol. 2020;268(8):2690-2696. https://doi.org/10.1007/s00415‐020‐10263‐1
  38. Huber M, Rogozinski S, Puppe W, et al. Postinfectious onset ofmyasthenia gravis in a COVID‐19 patient. Front Neurol. 2020;11:576153. https://doi.org/10.3389/fneur.2020.576153
  39. Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSKantibody‐associated myasthenia gravis with SARS‐CoV‐2 infection: a case report. Ann Intern Med. 2021;174(6):872‐873.  https://doi.org/10.7326/L20‐1298
  40. Assini A, Gandoglia I, Damato V, et al. Myasthenia gravis associated with anti‐MuSK antibodies developedafter SARS‐CoV‐2 infection. Eur J Neurol. 2021;28(10):3537‐3539. https://doi.org/10.1111/ene.14721
  41. Malik GR, Wolfe AR, Soriano R, et al. Injury‐prone: peripheral nerveinjuries associated with prone positioning for COVID‐19‐relatedacute respiratory distress syndrome. Br J Anaesth. 2020;125:478‐480.  https://doi.org/10.1016/j.bja.2020.08.045
  42. Zhou L, Siao P. Lateral femoral cutaneous neuropathy caused byprone positioning to treat COVID‐19‐associated acute respiratory distress syndrome. Muscle Nerve. 2021;63(6):50‐52.  https://doi.org/10.1002/mus.27202
  43. Ballve A, Llaurado A, Palasi A, et al. Weakness as a complication of COVID-19 in critically ill patients: clinical features and prognostic factors in a case series. Rev Neurol. 2021;73:10-16.  https://doi.org/10.33588/rn.7301.2021042
  44. Silva-Hernández L, Cabal-Paz B, Mayo-Canalejo D, Horga A. Post-COVID symptoms of potential peripheral nervous and muscular origin. Neurology Perspectives. November 2021. https://doi.org/10.1016/j.neurop.2021.11.002
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.